- Home
- SVV vs INBX Comparison
SVV vs INBX Comparison
Compare SVV & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVV | INBX |
|---|---|---|
| Founded | 1954 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SVV | INBX |
|---|---|---|
| Price | $8.49 | $70.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $13.67 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 133.4K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 649.90 |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $1,678,954,000.00 | $200,000.00 |
| Revenue This Year | $6.91 | $563.00 |
| Revenue Next Year | $7.58 | N/A |
| P/E Ratio | $62.32 | ★ N/A |
| Revenue Growth | ★ 9.19 | N/A |
| 52 Week Low | $6.48 | $10.81 |
| 52 Week High | $13.89 | $94.57 |
Technical Indicators
Market Signals| Indicator | SVV | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 27.73 | 42.15 |
| Support Level | $7.69 | $28.54 |
| Resistance Level | $11.21 | $85.97 |
| Average True Range (ATR) | 0.56 | 4.58 |
| MACD | -0.18 | -1.04 |
| Stochastic Oscillator | 10.46 | 25.72 |
Price Performance
Historical ComparisonAbout SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second-hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, and sells these items in its stores.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.